Drug intelligence / Profile preview

Ruibang

Development stage
Unknown
Lead developer
Zhejiang Ruibang Pharmaceutical
Modality
Small Molecules, Recombinant Proteins and Enzymes
Administration
Oral, Topical
01

Overview

Zhejiang Ruibang Pharmaceutical Co., LTD, operating under the brand name Ruibang, is a Chinese pharmaceutical manufacturer established in 1956. The company specializes in the research, development, manufacturing, and sale of a diverse portfolio of Active Pharmaceutical Ingredients (APIs) and finished drug products. Their product range includes antibiotics such as meleumycin, mupirocin, and fusidic acid; immunosuppressants like cyclosporine A; lipid-lowering agents such as simvastatin and lovastatin; and various mineral gluconates (e.g., calcium, zinc, magnesium, potassium, ferrous, copper gluconates) which also serve as nutritional supplements. Ruibang also produces riboflavin (Vitamin B2) and methylbenactyzine bromide. The company holds certifications from the U.S. FDA, Chinese GMP, and European GMP, indicating adherence to international quality standards. They also produce food-grade gluconate series and are involved in nutraceutical markets.

Brand names
Ruibang
Other names
瑞邦
02

Targets

IleRS (Isoleucyl-tRNA synthetase)

Beyond the preview

Go deeper on Ruibang.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ruibang.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call